EAHP’s SIG focused on in-vivo gene therapy medicinal products launches survey activity
EAHP's SIG focused on in-vivo gene therapy medicinal products launches survey activity
6 May 2022
The Special Interest Group on the hospital pharmacist's preparedness for in-vivo gene therapy medicinal products of the European Association of Hospital Pharmacists (EAHP) is conducting research. Due to the number of licensed formulations on the horizon, the SIG hopes to obtain information on the preparedness of hospital pharmacy departments for the delivery of in-vivo gene therapy medicines to their patients. All information obtained will be kept confidential and will not be used to identify any specific hospitals or individuals.
The survey includes questions touching on the hospital pharmacy facilities and the pharmacists working in these facilities. Hospital pharmacists that are not yet working with in-vivo gene therapies are also encouraged to participate in the survey.
EAHP's SIG is looking to receive one answer per hospital pharmacy/hospital. Participation is completely voluntary. It should take approximately 10 to 20 minutes to complete the survey. Feedback can be shared until the 3rd of June 2022 via the following LINK.
EAHP's SIG looks forward to receiving your input on the survey investigating the preparedness of hospital pharmacies for in-vivo gene therapy medicinal products.
ENDS
For further information contact info[at]eahp[dot]eu | 0032 2 669 2513
1. The European Association of Hospital Pharmacists (EAHP) is a not-for-profit organisation that defends the interests of more than 23.000 European hospital pharmacists from its 36 full and associate member organisations. EAHP works to develop knowledge on hospital pharmacy to ease the improvement of care and outcomes for patients in the hospital setting. The Association achieves this through science, practice, research, education, as well as sharing best-practice and responsibility with other healthcare professionals. More information about EAHP is available HERE.
2. Learn more about the SIG on the hospital pharmacist's preparedness for in-vivo gene therapy medicinal products HERE
3. Access the survey HERE
